About Chronix Biomedical
Chronix Biomedical is a company based in San Jose (United States) founded in 1997 was acquired by OncoCyte in February 2021.. Chronix Biomedical has raised $21.59 million across 9 funding rounds from investors including OncoCyte, Limitless Earth and Pentagram. The company has 2 employees as of December 31, 2022. Chronix Biomedical operates in a competitive market with competitors including Guardant Health, GRAIL, Color, Thrive Earlier Detection and Delfi Diagnostics, among others.
- Headquarter San Jose, United States
- Employees 2 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Chronix Biomedical Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Chronix Biomedical
Chronix Biomedical has successfully raised a total of $21.59M across 9 strategic funding rounds. The most recent funding activity was a Series E round of $100 thousand completed in September 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Series E — $100,000
-
First Round
First Round
(05 Aug 2008)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2019 | Amount | Series E - Chronix Biomedical | Valuation | Limitless Earth |
|
| Jul, 2017 | Amount | Series E - Chronix Biomedical | Valuation |
investors |
|
| May, 2017 | Amount | Series E - Chronix Biomedical | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Chronix Biomedical
Chronix Biomedical has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include OncoCyte, Limitless Earth and Pentagram. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Technology companies are invested in by the private equity firm.
|
Founded Year | Domain | Location | |
|
Venture capital funding is provided to innovative technology startups.
|
Founded Year | Domain | Location | |
|
Brand design services are provided globally by Pentagram.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Chronix Biomedical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Chronix Biomedical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Chronix Biomedical Comparisons
Competitors of Chronix Biomedical
Chronix Biomedical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, GRAIL, Color, Thrive Earlier Detection and Delfi Diagnostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Circulating tumor DNA is screened for early cancer detection.
|
|
| domain | founded_year | HQ Location |
Cancer care is delivered through a virtual clinic by Color.
|
|
| domain | founded_year | HQ Location |
Blood-based liquid biopsy tests for multiple cancer detection are provided.
|
|
| domain | founded_year | HQ Location |
Provider of DNA sequencing for cancer detection
|
|
| domain | founded_year | HQ Location |
Provider of cell-free cancer liquid biopsy test
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Chronix Biomedical
Frequently Asked Questions about Chronix Biomedical
When was Chronix Biomedical founded?
Chronix Biomedical was founded in 1997 and raised its 1st funding round 11 years after it was founded.
Where is Chronix Biomedical located?
Chronix Biomedical is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
Is Chronix Biomedical a funded company?
Chronix Biomedical is a funded company, having raised a total of $21.59M across 9 funding rounds to date. The company's 1st funding round was a Series E of $1.47M, raised on Aug 05, 2008.
How many employees does Chronix Biomedical have?
As of Dec 31, 2022, the latest employee count at Chronix Biomedical is 2.
What does Chronix Biomedical do?
Chronix Biomedical was founded in 1997 in San Jose, United States, within the biomedical sector. Focus is placed on non-invasive diagnostics for cancer, including the Second Opinion blood test used alongside PSA screening to minimize false positives in prostate cancer cases. Development also includes a biomarker test for detecting minimal residual disease following chemotherapy treatments. Operations center on advancing these diagnostic tools for clinical use.
Who are the top competitors of Chronix Biomedical?
Chronix Biomedical's top competitors include Guardant Health, GRAIL and BillionToOne.
Who are Chronix Biomedical's investors?
Chronix Biomedical has 4 investors. Key investors include OncoCyte, Limitless Earth, Pentagram, and PrairieGold Venture Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.